Eli Lilly Stock Soars as Zepbound and Mounjaro Sales Crush Estimates; 2024 Guidance Hiked
A Blockbuster Quarter Driven by Weight-Loss Giants Pharmaceutical giant Eli Lilly has delivered a stunning first-quarter performance, shattering Wall Street expectations and raising its full-year financial forecast. This remarkable success is powered by the soaring…
